Answers are grounded in this paper and cite their sources.
Key Recommendations for clinical practice• Anaphylaxis is a potentially life-threatening allergic reaction.• Recognise anaphylaxis based on: > Sudden onset and rapid progression of symptoms > Airway and/or Breathing and/or Circulation problems > Skin and/or mucosal changes (flushing, urticaria, angioedema) > Exposure to a known allergen for the patient supports the diagnosis.• Treat life-threatening features, using the Airway, Breathing, Circulation, Disability, Exposure (ABCDE) approach.• Give intramuscular (IM) adrenaline early for Airway/Breathing/Circulation problems.Adrenaline is the first-line treatment for anaphylaxis. A single dose of IM adrenaline is well-tolerated and poses minimal risk in the context of an individual having an allergic reaction.If in doubt, give IM adrenaline. Repeat IM adrenaline every 5 minutes if features of anaphylaxis do not resolve.• Intravenous (IV) adrenaline must only be used in certain specialist settings and only by those skilled and experienced in its use.> IV adrenaline infusions form the basis of treatment for refractory anaphylaxis: seek expert help early in patients with anaphylaxis refractory to 2 doses of IM adrenaline.
No takes yet. Share an insight, caveat, or question.
Team DFTB (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: